doi: 10.1016/j.lfs.2017.10.021 36 ChauhanGRoyKKumarGKumariPAlamSKishoreKet al
Patients with specific genetic profiles may require slower dose escalation schedules or additional micronutrient support to avoid muscle pain and other adjustment symptoms
The Food and Drug Administration recommends avoiding weight-loss drugs during pregnancy, and there is currently no data to support the use of the medications after conception
Overall, while L-carnitine may potentially contribute to weight loss efforts, its role as a standalone weight loss solution remains uncertain, and more research is needed to be more certain in understanding its effects in this context
Read the latest: To view or add a comment, sign in More Relevant Posts Employers are facing unprecedented cost pressures from the rapid surge in GLP1 utilization
Platelet replacement for patients on anti-platelet agents Though intuitive that replacing platelets for those on medications that inhibit platelet function, studies such as the PATCH Trial for intracranial hemorrhage [8] have found that there is an increased risk of death and length of hospitalization due to associated thromboembolism
